Published

Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.

No abstract is available for this record.

Open source BibTeX RIS

Bibliographic context

Journal: Frontiers in psychiatry
Date: 2022-12-31
Source: PubMed
DOI: 10.3389/fpsyt.2023.1305478
PubMed: 37928914

Authors

Barnett BS Bassir Nia A Sackett NB Weleff J

Watch author

Topics and keywords

psilocybin Addiction Mechanism of Action Safety Other addiction ketamine psilocybin psychedelics substance use disorder

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARASAIMSARA Journal · 2026-06-14 Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticityTranslational Psychiatry · 2026-06-04 Balancing safety and access in Oregon’s psilocybin servicesInternational Journal of Drug Policy · 2026-06-12 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal CortexEuropean Journal of Neuroscience · 2026-05-31 The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising ApproachDigital Showcase Research, Scholarship, & Creative Works (University of Lynchburg) · 2026-05-21 Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybinJournal of Pre-Clinical and Clinical Research · 2026-05-11 Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-06 Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USAAJPM Focus · 2026-04-30